Bioinformatics tools: choosing between free bioinformatic tools, hosted platforms and a bioinformatics tool your lab must maintain

Deciding what to run and where

1. Start from the analysis, not the platform. Write down the analyses the lab actually performs and how often. Most labs do a small number of things repeatedly, and a platform bought for the breadth of its catalogue is usually bought for features nobody will use.
2. Count the true cost of free. Open tools cost nothing to license and require someone competent to install, update, parameterise and interpret them. If that person exists and has the time, free tools are usually better because they are what the literature uses. If they do not, a hosted platform is cheaper than the post that would be needed.
3. Reproducibility is a requirement, not a feature. A result you cannot reproduce is a result you cannot defend. Require versioned tools, recorded parameters and a captured environment, whether that comes from a workflow manager and containers or from a platform that records provenance for you.
4. Data movement and storage dominate at scale. Sequencing output is large, and moving it repeatedly between storage and compute is often the slowest and most expensive part of the workflow. Decide where the data lives before choosing where the analysis runs, because the second follows the first.
5. Check the exit. Ask how results and raw data leave a hosted platform, in what formats, and what happens at the end of a contract. A platform that holds your analysis history in a form you cannot export is a platform you cannot leave.

The public archives everything rests on

Sequence databases, similarity search services and the annotation resources maintained by the public institutes are the foundation under both free and commercial tools, and a commercial platform is usually packaging access to them alongside its own workflow layer. Understanding which part you are paying for makes the comparison much clearer.

Submission requirements matter too. Journals and funders expect data deposited in the public archives, so a workflow that cannot produce a submission-ready package creates work at the point you least want it.

Support, training and the bus factor

The most common failure in laboratory bioinformatics is not a bad tool; it is a single person who built everything leaving. Whatever route you take, insist that workflows are written down, version controlled and runnable by someone else.

For commercial platforms, ask what support actually means in practice and ask a reference customer rather than the vendor. For open tools, prefer projects with active maintenance and a real user community over the most recently published one.

Common questions

Do I need to pay for bioinformatics tools?

Rarely for the analysis itself, since the widely used tools are free and open. You pay for the people, the compute and the reproducibility infrastructure, or you pay a platform to provide those instead.

What makes a bioinformatics result reproducible?

Recorded tool versions, recorded parameters, a captured software environment and the input data identified unambiguously. Workflow managers with containers give this, and some platforms record it automatically.

Cloud or local compute?

Follow the data. If the data is generated locally and stays local, local compute avoids transfer costs and delays. If it arrives from a sequencing provider in the cloud, analysing it there is usually faster and cheaper.

How do I avoid depending on one person?

Require that every routine workflow is written down, version controlled and demonstrably runnable by a second person. This is a management decision rather than a software one and it is the one that actually protects the lab.

Browse by service class

• Compare Gene synthesis on advertised prices